StockVS

Willow Lane Acquisition Corp. II (WLIIU) 股票分析

金融服务

Willow Lane Acquisition Corp. II

$10.27

+$0.09 (+0.88%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Willow Lane Acquisition Corp. II is a financial services entity structured specifically to execute a business combination, which may take the form of a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or a similar transaction with one or more target businesses. The company operates within the shell companies industry, a classification that defines its current status as a special purpose acquisition company (SPAC) awaiting a definitive merger with a private operating business. The market capitalization, price-to-book ratio, and annual revenue figures for this entity are currently not available in standard financial reporting, while the specific count of employees is also not disclosed. This lack of traditional scale metrics such as a defined market cap or revenue stream indicates that the company's valuation is entirely dependent on the outcome of its pending business combination, reflecting the transitional nature of its business model before it transforms into an operating entity.

财务健康

The reported net income for the trailing twelve months stands at a loss of $105,437, while both revenue and EBITDA figures are not available for this period. The significant gap between the nominal revenue status and the substantial net loss reveals a cost structure characterized by high operating expenses relative to any minimal revenue generation typical of pre-merger shell companies. Free cash flow and the specific amount of cash on hand are not reported, suggesting that the company's financial flexibility is currently constrained by its primary objective of raising capital for a merger rather than generating operational cash flows. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which indicates that the company has not yet established a profitable revenue stream prior to its business combination. Total debt is reported as $0, creating a stark contrast with the unreported cash balance, and the debt-to-equity ratio is similarly not available. Despite the absence of debt, the current ratio is 0.04, a figure that indicates a potential liquidity constraint where current liabilities significantly exceed current assets in the absence of sufficient cash reserves. Furthermore, the return on equity and return on assets are not available, meaning that these return metrics cannot yet reveal the management effectiveness required to generate shareholder value in the absence of a completed merger.

估值评估

The trailing price-to-earnings ratio and forward price-to-earnings ratio are both not available due to the company's unprofitable status and lack of consistent earnings history. The price-to-book ratio is reported at -2532.50, a negative figure that indicates the market valuation is detached from the company's book value in the traditional sense, reflecting the speculative nature of shell companies that have not yet identified a target. Neither the price-to-sales ratio nor the enterprise value-to-EBITDA multiple can be calculated as these alternative valuation metrics are not applicable given the missing sales and earnings data. The 52-week high is recorded at $10.20 and the 52-week low at $10.06, placing the current trading price within a very narrow band near the lower end of its recent trading range. The beta value is not available, which prevents a direct comparison of the stock's price volatility relative to the broader market, though the tight trading range suggests limited price movement over the past year. These valuation characteristics collectively illustrate a financial profile where traditional multiples are ineffective and the asset price is primarily driven by SPAC-specific market dynamics rather than fundamental earnings performance.

Growth & Income

Both the year-over-year revenue growth rate and the earnings growth rate are not available, as the company has not yet realized significant revenue growth or earnings expansion prior to its merger. Since the company does not pay a dividend, there is no dividend yield or payout ratio to evaluate for sustainability, indicating that any earnings generated post-merger will be reinvested into the business rather than distributed to shareholders. Consequently, the company's strategy focuses on capital preservation and eventual business combination rather than providing current income to investors through dividends. The overall growth and income profile is currently defined by the potential for a binary outcome upon merger, with no historical growth trajectory or income distribution to serve as a benchmark for performance analysis.

同行比较

Willow Lane Acquisition Corp. II (WLIIU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Willow Lane Acquisition Corp. II WLIIU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Willow Lane Acquisition Corp. II的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Willow Lane Acquisition Corp. II

Willow Lane Acquisition Corp. II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.

公司简介以英文显示。

关键指标

市值
N/A
市盈率
N/A
52周最高
$10.50
52周最低
$10.05
平均成交量
9.28K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States